Mohsen Khademi

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025;96(11):1046-1052
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis
Abdelhak A; Bachhuber F; Ning K; Benkert P; Boscardin WJ; Maceski AM; Schaedelin S; Achtnichts L; Finkener S; Lalive PH; Uginet M; Pot C; Du Pasquier R; Hoepner R; Chan A; Gobbi C; Zecca C; Mueller S; Roth P; Granziera C; Chitnis T; Madill E; Weiner HL; Green AJ; Hauser SL; Cree BAC; Kuempfel T; Havla J; Skripuletz T; Gingele S; Senel M; Vardakas I; Taranu D; Ziemann U; Kowarik MC; Kleiter I; Hoshi M-M; Zettl UK; Haarmann A; Thebault S; Freedman MS; Bergman HP; Iacobaeus E; Khademi M; Ferraro D; Cardi M; Mariotto S; Comabella M; Montalban X; Vilaseca-Jolonch A; Strijbis EM; Wessels MHJ; Killestein J; Hemmer B; Held F; Sellebjerg F; Hojsgaard Chow H; Alvarez-Lafuente R; Dominguez-Mozo MI; Hegen H; Berek K; Deisenhammer F; Thouvenot E; Agherbi H; Rejdak K; Gasior M; Tzanetakos D; Tzartos JS; Sormani MP; Basuroski ID; Arrambide G; Khalil M; Piehl F; Teunissen CE; Kuhle J; Tumani H
Journal article: BRAIN. 2025;:awaf345
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
Furlan R; Schaedelin S; Frederiksen JL; Watanabe M; Piehl F; Fink K; Iacobaeus E; Evertsson B; Khademi M; Gastaldi M; Greco G; Mariotto S; Carta S; Di Sapio A; Bava CI; Giorgi L; Benkert P; Maceski AM; Oechtering J; Willemse E; Pröbstel A-K; Pretzsch R; Finardi A; Mandelli A; Anthony D; Kuhle J; Leppert D
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2025;32(7):e70291
Kappa Free Light Chain Index Correlates With Prognostic Biomarkers in Multiple Sclerosis and Decreases Slowly Following Treatment
Duell F; Hogelin KA; Vlad B; Neidhart S; Khademi M; Jelcic I; Hansson M; Al Nimer F
Article: CELL REPORTS MEDICINE. 2025;6(3):102027
T-bet+CXCR3+B cells drive hyperreactive B-T cell interactions in multiple sclerosis
Jelcic I; Naghavian R; Fanaswala I; Macnair W; Esposito C; Calini D; Han Y; Marti Z; Raposo C; del Castillo JS; Oldrati P; Erny D; Kana V; Zheleznyakova G; Al Nimer F; Tackenberg B; Reichen I; Khademi M; Piehl F; Robinson MD; Jelcic I; Sospedra M; Pelkmans L; Malhotra D; Reynolds R; Jagodic M; Martin R
Article: ANTIBODIES. 2024;13(4):102
Intensity of Intrathecal Total IgG Synthesis in Multiple Sclerosis Correlates with the Degree of Pleocytosis, Diversity of Intrathecal Antiviral Antibody Specificities, and Female Sex
Vlad B; Hilty M; Neidhart S; Hoegelin KA; Ziegler M; Khademi M; Lutterotti A; Regeniter A; Martin R; Al Nimer F; Jelcic I
Article: MULTIPLE SCLEROSIS JOURNAL. 2024;30(13):1598-1608
Intrathecal immune reactivity against Measles-, Rubella-, and Varicella Zoster viruses is associated with cerebrospinal fluid inflammation in multiple sclerosis
Vlad B; Neidhart S; Hilty M; Hogelin KA; Reichen I; Ziegler M; Khademi M; Lutterotti A; Regeniter A; Martin R; Al Nimer F; Jelcic I
Article: BRAIN. 2024;147(10):3573-3582
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
Huang J; Tengvall K; Lima IB; Hedstroem AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundstroem P; Waterboer T; Olsson T; Kockum I
Article: ANNALS OF NEUROLOGY. 2024;95(6):1112-1126
HLA Associations of Intrathecal IgG Production against Specific Viruses in Multiple Sclerosis
Neidhart S; Vlad B; Hilty M; Hogelin KA; Ziegler M; Berenjeno-Correa E; Reichen I; Stridh P; Jelcic I; Khademi M; Kockum I; Sospedra M; Al Nimer F; Martin R; Jelcic I
Article: CELL REPORTS MEDICINE. 2024;5(1):101351
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis
Ulutekin C; Galli E; Schreiner B; Khademi M; Callegari I; Piehl F; Sanderson N; Kirschenbaum D; Mundt S; Filippi M; Furlan R; Olsson T; Derfuss T; Ingelfinger F; Becher B
Article: CLINICAL IMMUNOLOGY. 2024;258:109870
B cell activating factor levels are linked to distinct B cell markers in multiple sclerosis and following B cell depletion and repopulation
Hogelin KA; Isac B; Khademi M; Al Nimer F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2023;30(12):3789-3798
The impact of hybrid immunity on immune responses after SARS-CoV-2 vaccination in persons with multiple sclerosis treated with disease-modifying therapies
Rabenstein M; Thomas OG; Carlin G; Khademi M; Hogelin KA; Malmestrom C; Axelsson M; Brandt AF; Gafvelin G; Gronlund H; Kockum I; Piehl F; Lycke J; Olsson T; Hessa T
Article: NATURE COMMUNICATIONS. 2023;14(1):6903
Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosis
Akesson J; Hojjati S; Hellberg S; Raffetseder J; Khademi M; Rynkowski R; Kockum I; Altafini C; Lubovac-Pilav Z; Mellergard J; Jenmalm MC; Piehl F; Olsson T; Ernerudh J; Gustafsson M
Article: JOURNAL OF NEUROINFLAMMATION. 2023;20(1):189
Cerebrospinal fluid levels of neuroinflammatory biomarkers are increased in athletes with persistent post-concussive symptoms following sports-related concussion
Gard A; Vedung F; Piehl F; Khademi M; Wernersson MP; Rorsman I; Tegner Y; Pessah-Rasmussen H; Ruscher K; Marklund N
Article: SCIENCE ADVANCES. 2023;9(20):eadg3032
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
Thomas OG; Bronge M; Tengvall K; Akpinar B; Nilsson OB; Holmgren E; Hessa T; Gafvelin G; Khademi M; Alfredsson L; Martin R; Guerreiro-Cacais AO; Groenlund H; Olsson T; Kockum I
Article: JOURNAL OF NEUROINFLAMMATION. 2023;20(1):98
Prominent epigenetic and transcriptomic changes in CD4⁺ and CD8⁺ T cells during and after pregnancy in women with multiple sclerosis and controls
Zenere A; Hellberg S; Lingehed GP; Svenvik M; Mellergard J; Dahle C; Vrethem M; Raffetseder J; Khademi M; Olsson T; Blomberg M; Jenmalm MC; Altafini C; Gustafsson M; Ernerudh J
Article: BRAIN AND BEHAVIOR. 2023;13(1):e2873
Demographic and disease-related factors impact on cerebrospinal fluid neurofilament light chain levels in multiple sclerosis
Revendova KZ; Cucuzza CS; Manouchehrinia A; Khademi M; Bar M; Leppert D; Sandberg E; Ouellette R; Granberg T; Piehl F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2022;29(11):3317-3328
B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients
Hogelin KA; Ruffin N; Pin E; Hober S; Nilsson P; Cucuzza CS; Khademi M; Olsson T; Piehl F; Al Nimer F
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:930947
Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy
Lingehed GP; Hellberg S; Huang J; Khademi M; Kockum I; Carlsson H; Tjernberg I; Svenvik M; Lind J; Blomberg M; Vrethem M; Mellergard J; Gustafsson M; Jenmalm MC; Olsson T; Ernerudh J
Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(7):962-976
Copy number variations across the blood-brain barrier in multiple sclerosis
Bedri SK; Evertsson B; Khademi M; Al Nimer F; Olsson T; Hillert J; Glaser A
Article: SCIENCE ADVANCES. 2022;8(17):eabn1823
Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
Bronge M; Hogelin KA; Thomas OG; Ruhrmann S; Carvalho-Queiroz C; Nilsson OB; Kaiser A; Zeitelhofer M; Holmgren E; Linnerbauer M; Adzemovic MZ; Hellstrom C; Jelcic I; Liu H; Nilsson P; Hillert J; Brundin L; Fink K; Kockum I; Tengvall K; Martin R; Tegel H; Graslund T; Al Nimer F; Guerreiro-Cacais AO; Khademi M; Gafvelin G; Olsson T; Gronlund H
Article: EPIGENOMICS. 2021;13(20):1607-1618
Deep characterization of paired chromatin and transcriptomes in four immune cell types from multiple sclerosis patients
Fernandes SJ; Ericsson M; Khademi M; Jagodic M; Olsson T; Gomez-Cabrero D; Kockum I; Tegner J
Article: ISCIENCE. 2021;24(9):103078
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Hogelin KA; Ruffin N; Pin E; Manberg A; Hober S; Gafvelin G; Gronlund H; Nilsson P; Khademi M; Olsson T; Piehl F; Al Nimer F
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(17):e2011574118
Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology
Zheleznyakova GY; Piket E; Needhamsen M; Hagemann-Jensen M; Ekman D; Han Y; James T; Khademi M; Al Nimer F; Scicluna P; Huang J; Kockum I; Faridani OR; Olsson T; Piehl F; Jagodic M
Article: MOLECULAR & CELLULAR PROTEOMICS. 2021;20:100157
Assessing the Preanalytical Variability of Plasma and Cerebrospinal Fluid Processing and Its Effects on Inflammation-Related Protein Biomarkers
Huang J; Khademi M; Lindhe O; Jonsson G; Piehl F; Olsson T; Kockum I
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2020;8(1):207
Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS
Gerhards R; Pfeffer LK; Lorenz J; Starost L; Nowack L; Thaler FS; Schlueter M; Ruebsamen H; Macrini C; Winklmeier S; Mader S; Bronge M; Groenlund H; Feederle R; Hsia H-E; Lichtenthaler SF; Merl-Pham J; Hauck SM; Kuhlmann T; Bauer IJ; Beltran E; Gerdes LA; Mezydlo A; Bar-Or A; Banwell B; Khademi M; Olsson T; Hohlfeld R; Lassmann H; Kuempfel T; Kawakami N; Meinl E
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2020;7(4):e775
Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
Duell F; Evertsson B; Al Nimer F; Sandin A; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(23):12952-12960
Inflammation-related plasma and CSF biomarkers for sclerosis
Huang J; Khademi M; Fugger L; Lindhe O; Novakova L; Axelsson M; Malmestrom C; Constantinescu C; Lycke J; Piehl F; Olsson T; Kockum I
Article: NEUROLOGY. 2020;94(23):e2457-e2467
Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis
Manouchehrinia A; Stridh P; Khademi M; Leppert D; Barro C; Michalak Z; Benkert P; Lycke J; Alfredsson L; Kappos L; Piehl F; Olsson T; Kuhle J; Kockum I
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2020;27(2):297-307
Epilepsy in systemic lupus erythematosus: prevalence and risk factors
Hopia L; Andersson M; Svenungsson E; Khademi M; Piehl F; Tomson T
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2715
Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis
Engdahl E; Gustafsson R; Huang J; Bistrom M; Bomfim IL; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedstrom AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundstrom P; Olsson T; Kockum I; Fogdell-Hahn A
Article: SCIENTIFIC REPORTS. 2019;9(1):11996
Non-parametric combination analysis of multiple data types enables detection of novel regulatory mechanisms in T cells of multiple sclerosis patients
Fernandes SJ; Morikawa H; Ewing E; Ruhrmann S; Joshi RN; Lagani V; Karathanasis N; Khademi M; Planell N; Schmidt A; Tsamardinos I; Olsson T; Piehl F; Kockum I; Jagodic M; Tegner J; Gomez-Cabrero D
Article: JOURNAL OF IMMUNOLOGY. 2019;203(4):888-898
IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis
Lindahl H; Guerreiro-Cacais AO; Bedri SK; Linnerbauer M; Linden M; Abdelmagid N; Tandre K; Hollins C; Irving L; Glover C; Jones C; Alfredsson L; Ronnblom L; Kockum I; Khademi M; Jagodic M; Olsson T
Article: JOURNAL OF AUTOIMMUNITY. 2019;102:38-49
Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis
Bronge M; Ruhrrnann S; Carvalho-Queiroz C; Nilsson OB; Kaiser A; Holmgren E; Macrini C; Winkhneier S; Meinl E; Brundin L; Khademi M; Olsson T; Gafvelin G; Gronlund H
Article: NATURE MEDICINE. 2019;25(8):1290-1300
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis
Galli E; Hartmann FJ; Schreiner B; Ingelfinger F; Arvaniti E; Diebold M; Mrdjen D; van der Meer F; Krieg C; Al Nimer F; Sanderson N; Stadelmann C; Khademi M; Piehl F; Claassen M; Derfuss T; Olsson T; Becher B
Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):60
Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment
Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maitre E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson P-J; Lampa J
Article: EBIOMEDICINE. 2019;40:517-527
B cell alterations during BAFF inhibition with belimumab in SLE
Ramskold D; Parodis I; Lakshmikanth T; Sippl N; Khademi M; Chen Y; Zickert A; Mikes J; Achour A; Amara K; Piehl F; Brodin P; Gunnarsson I; Malmstrom V
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;49(2):313-322
miR-31 regulates energy metabolism and is suppressed in Tcells from patients with Sjogren's syndrome
Johansson A; Nyberg WA; Sjostrand M; Moruzzi N; Bergman P; Khademi M; Andersson M; Piehl F; Berggren P-O; Covacu R; Jagodic M; Espinosa A
Article: CELL. 2018;175(1):85-100.e23
Memory B Cells Activate Brain-Homing, Autoreactive CD4⁺ T Cells in Multiple Sclerosis
Jelcic I; Al Nimer F; Wang J; Lentsch V; Planas R; Jelcic I; Madjovski A; Ruhrmann S; Faigle W; Frauenknecht K; Pinilla C; Santos R; Hammer C; Ortiz Y; Opitz L; Gronlund H; Rogler G; Boyman O; Reynolds R; Lutterotti A; Khademi M; Olsson T; Piehl F; Sospedra M; Martin R
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2018;5(5):e491
Identification of MS-specific serum miRNAs in an international multicenter study
Regev K; Healy BC; Paul A; Diaz-Cruz C; Mazzola MA; Raheja R; Glanz BI; Kivisakk P; Chitnis T; Jagodic M; Piehl F; Olsson T; Khademi M; Hauser S; Oksenberg J; Khoury SJ; Weiner HL; Gandhi R
Article: MULTIPLE SCLEROSIS JOURNAL. 2018;24(8):1046-1054
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Piehl F; Kockum I; Khademi M; Blennow K; Lycke J; Zetterberg H; Olsson T
Article: HUMAN MOLECULAR GENETICS. 2018;27(5):912-928
Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients
James T; Linden M; Morikawa H; Fernandes SJ; Ruhrmann S; Huss M; Brandi M; Piehl F; Jagodic M; Tegner J; Khademi M; Olsson T; Gomez-Cabrero D; Kockum I
Article: NEUROLOGY. 2017;89(22):2230-2237
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Novakova L; Zetterberg H; Sundstrom P; Axelsson M; Khademi M; Gunnarsson M; Malmestrom C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Article: VIRAL IMMUNOLOGY. 2017;30(8):590-600
Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls
Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlstroem L; Lamb F; Khademi M; Ambati A; Maeurer M; Bomfim IL; Fink K; Fex M; Torn C; Elding Larsson H; Lernmark A
Article: JOURNAL OF NEUROCHEMISTRY. 2017;141(2):296-304
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmestrom C; Piehl F; Olsson T; Lycke J
Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(1):62-71
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmestrom C; Piehl F; Olsson T; Lycke J
Article: AUTOIMMUNITY. 2016;49(6):421-433
Autoantibody targets in vaccine-associated narcolepsy
Haggmark-Manberg A; Zandian A; Forsstrom B; Khademi M; Bomfim IL; Hellstrom C; Arnheim-Dahlstrom L; Hallbook T; Darin N; Lundberg IE; Uhlen M; Partinen M; Schwenk JM; Olsson T; Nilsson P
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(4):e256
Absence of systemic oxidative stress and increased CSF prostaglandin F_2α in progressive MS
Lam MA; Maghzal GJ; Khademi M; Piehl F; Ratzer R; Christensen JR; Sellebjerg FT; Olsson T; Stocker R
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016;113(28):7864-7869
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
Braendle SM; Obermeier B; Senel M; Bruder J; Mentele R; Khademi M; Olsson T; Tumani H; Kristoferitsch W; Lottspeich F; Wekerle H; Hohlfeld R; Dornmair K
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(3):e219
Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis
Bergman P; Piket E; Khademi M; James T; Brundin L; Olsson T; Piehl F; Jagodic M
Article: PLOS ONE. 2016;11(5):e0155832
Von Willebrand Factor Gene Variants Associate with Herpes simplex Encephalitis
Abdelmagid N; Bereczky-Veress B; Atanur S; Musilova A; Zidek V; Saba L; Warnecke A; Khademi M; Studahl M; Aurelius E; Hjalmarsson A; Garcia-Diaz A; Denis CV; Bergstrom T; Skoldenberg B; Kockum I; Aitman T; Huebner N; Olsson T; Pravenec M; Diez M
Article: CLINICAL IMMUNOLOGY. 2016;166:89-95
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function
Lindblom RPF; Aeinehband S; Strom M; Al Nimer F; Sandholm K; Khademi M; Nilsson B; Piehl F; Ekdahl KN
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016;113(8):2188-2193
Anoctamin 2 identified as an autoimmune target in multiple sclerosis
Ayoglu B; Mitsios N; Kockum I; Khademi M; Zandian A; Sjoberg R; Forsstrom B; Bredenberg J; Bomfim IL; Holmgren E; Gronlund H; Guerreiro-Cacais AO; Abdelmagid N; Uhlen M; Waterboer T; Alfredsson L; Mulder J; Schwenk JM; Olsson T; Nilsson P
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2016;3(1):e191
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
Al Nimer F; Elliott C; Bergman J; Khademi M; Dring AM; Aeinehband S; Bergenheim T; Christensen JR; Sellebjerg F; Svenningsson A; Linington C; Olsson T; Piehl F
Article: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2016;87(2):126-129
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
Disanto G; Adiutori R; Dobson R; Martinelli V; Costa GD; Runia T; Evdoshenko E; Thouvenot E; Trojano M; Norgren N; Teunissen C; Kappos L; Giovannoni G; Kuhle J; Bianchi L; Topping J; Bestwick JP; Meier U-C; Lazareva N; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeno JC; Kleinova P; Horakova D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martinez AD; Carra A; Salvetti M; Uccelli A; Torkildsen O; Myhr K; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg RLP; Yaldizli O; Vecsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdova E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Montalban X; Tintore M; Olsson T; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Furlan R; Comi G; Ramagopalan SV
Article: BRAIN BEHAVIOR AND IMMUNITY. 2016;51:47-55
Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms
Aeinehband S; Brenner P; Stahl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Article: JOURNAL OF NEUROINFLAMMATION. 2015;12:235
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid
Wuhrer M; Selman MHJ; McDonnell LA; Kuempfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):264-276
Increased -haemolytic group A streptococcal M6 serotype and streptodornase B-specific cellular immune responses in Swedish narcolepsy cases
Ambati A; Poiret T; Svahn B-M; Valentini D; Khademi M; Kockum I; Lima I; Arnheim-Dahlstrom L; Lamb F; Fink K; Meng Q; Kumar A; Rane L; Olsson T; Maeurer M
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(10):1271-1279
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis
Checa A; Khademi M; Sar DG; Haeggstroem JZ; Lundberg JO; Piehl F; Olsson T; Wheelock CE
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(8):1013-1024
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier U-C; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeno JC; Kleinova P; Horakova D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martinez AD; Carra A; Salvetti M; Uccelli A; Torkildsen O; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg RLP; Yaldizli O; Vecsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdova E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintore M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
Article: NATURE COMMUNICATIONS. 2015;6:7333
γ-secretase directly sheds the survival receptor BCMA from plasma cells
Laurent SA; Hoffmann FS; Kuhn P-H; Cheng Q; Chu Y; Schmidt-Supprian M; Hauck SM; Schuh E; Krumbholz M; Ruebsamen H; Wanngren J; Khademi M; Olsson T; Alexander T; Hiepe F; Pfister H-W; Weber F; Jenne D; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Article: PLOS ONE. 2015;10(4):e0122048
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis
Aeinehband S; Lindblom RPF; Al Nimer F; Vijayaraghavan S; Sandholm K; Khademi M; Olsson T; Nilsson B; Ekdahl KN; Darreh-Shori T; Piehl F
Article: BRAIN. 2015;138(Pt 4):918-931
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Canto E; Tintore M; Villar LM; Costa C; Nurtdinov R; Alvarez-Cermeno JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodriguez-Martin E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; Antonio Garcia-Merino J; Jos Sanchez A; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andres C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sanchez A; Rovira A; Montalban X; Comabella M
Article: JOURNAL OF IMMUNOLOGY. 2015;194(2):542-552
The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity
Hoffmann FS; Kuhn P-H; Laurent SA; Hauck SM; Berer K; Wendlinger SA; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister H-W; Alexander T; Hiepe F; Kuempfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Article: MULTIPLE SCLEROSIS JOURNAL. 2015;21(1):48-56
Age-dependent effects on the treatment response of natalizumab in MS patients
Matell H; Lycke J; Svenningsson A; Holmen C; Khademi M; Hillert J; Olsson T; Piehl F
Article: JOURNAL OF PROTEOME RESEARCH. 2014;13(11):4607-4619
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis
Bystrom S; Ayoglu B; Haggmark A; Mitsios N; Hong M-G; Drobin K; Forsstrom B; Fredolini C; Khademi M; Amor S; Uhlen M; Olsson T; Mulder J; Nilsson P; Schwenk JM
Article: NATURE COMMUNICATIONS. 2014;5:5056
Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human T_H cells
Hartmann FJ; Khademi M; Aram J; Ammann S; Kockum I; Constantinescu C; Gran B; Piehl F; Olsson T; Codarri L; Becher B
Article: JOURNAL OF AUTOIMMUNITY. 2014;50:99-106
A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010
Lind A; Ramelius A; Olsson T; Arnheim-Dahlstrom L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson A-L; Bomfim IL; Fink K; Lernmark A
Article: PLOS PATHOGENS. 2014;10(4):e1004084
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
Sundqvist E; Buck D; Warnke C; Albrecht E; Gieger C; Khademi M; Bomfim IL; Fogdell-Hahn A; Link J; Alfredsson L; Sondergaard HB; Hillert J; Oturai AB; Hemme B; Kockum I; Olsson T
Article: MOLECULAR & CELLULAR PROTEOMICS. 2013;12(9):2657-2672
Autoantibody Profiling in Multiple Sclerosis Using Arrays of Human Protein Fragments
Ayoglu B; Haggmark A; Khademi M; Olsson T; Uhlen M; Schwenk JM; Nilsson P
Article: PROTEOMICS. 2013;13(15):2256-2267
Antibody-based profiling of cerebrospinal fluid within multiple sclerosis
Haggmark A; Bystrom S; Ayoglu B; Qundos U; Uhlen M; Khademi M; Olsson T; Schwenk JM; Nilsson P
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(7):877-884
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Christensen JR; Bornsen L; Khademi M; Olsson T; Jensen PE; Sorensen PS; Sellebjerg F
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(7):863-870
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13
Linden M; Khademi M; Bomfim IL; Piehl F; Jagodic M; Kockum I; Olsson T
Article: MULTIPLE SCLEROSIS JOURNAL. 2013;19(7):871-876
Serum levels of LIGHT in MS
Malmestrom C; Gillett A; Jernas M; Khademi M; Axelsson M; Kockum I; Mattsson N; Zetterberg H; Blennow K; Alfredsson L; Wadenvik H; Lycke J; Olsson T; Olsson B
Article: PLOS ONE. 2013;8(5):e63172
Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
Khademi M; Dring AM; Gilthorpe JD; Wuolikainen A; Al Nimer F; Harris RA; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
Article: LUPUS. 2013;22(3):307-311
Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents
Iacobaeus E; Hopia L; Khademi M; Lunden M; Hammarin A-L; Svenungsson E; Andersson M
Article: JOURNAL OF PROTEOME RESEARCH. 2013;12(3):1101-1107
Effects of Natalizumab Treatment on the Cerebrospinal Fluid Proteome of Multiple Sclerosis Patients
Stoop MP; Singh V; Stingl C; Martin R; Khademi M; Olsson T; Hintzen RQ; Luider TM
Article: PLOS ONE. 2013;8(3):e57820
Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17-and Activated B-Cells and Correlates with Progression
Christensen JR; Bornsen L; Ratzer R; Piehl F; Khademi M; Olsson T; Sorensen PS; Sellebjerg F
Article: NEUROLOGY. 2012;79(23):2241-2248
Neurofascin as a target for autoantibodies in peripheral neuropathies
Ng JKM; Malotka J; Kawakami N; Derfuss T; Khademi M; Olsson T; Linington C; Odaka M; Tackenberg B; Pruess H; Schwab JM; Harms L; Harms H; Sommer C; Rasband MN; Eshed-Eisenbach Y; Peles E; Hohlfeld R; Yuki N; Dornmair K; Meinl E
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2012;170(2):149-155
FOXP3, CBLB and ITCH gene expression and cytotoxic T lymphocyte antigen 4 expression on CD4+CD25high T cells in multiple sclerosis
Sellebjerg F; Krakauer M; Khademi M; Olsson T; Sorensen PS
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(31):12728-12733
Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice
Lampa J; Westman M; Kadetoff D; Agreus AN; Le Maitre E; Gillis-Haegerstrand C; Andersson M; Khademi M; Corr M; Christianson CA; Delaney A; Yaksh TL; Kosek E; Svensson CI
Article: JOURNAL OF NEUROINFLAMMATION. 2012;9:167
Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up
Gonzalez H; Khademi M; Borg K; Olsson T
Article: SCIENCE TRANSLATIONAL MEDICINE. 2012;4(137):137ra73
Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
Ho PP; Kanter JL; Johnson AM; Srinagesh HK; Chang E-J; Purdy TM; van Haren K; Wikoff WR; Kind T; Khademi M; Matloff LY; Narayana S; Hur EM; Lindstrom TM; He Z; Fiehn O; Olsson T; Han X; Han MH; Steinman L; Robinson WH
Article: GENOME MEDICINE. 2012;4(1):2
The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls
Ronninger M; Guo Y; Shchetynsky K; Hill A; Khademi M; Olsson T; Reddy PS; Seddighzadeh M; Clark JD; Lin L-L; O'Toole M; Padyukov L
Article: HLA. 2011;78(4):271-274
No evidence of IL21 association with multiple sclerosis in a Swedish population
Linden M; Nohra R; Sundqvist E; Khademi M; Hillert J; Alfredsson L; Olsson T; Kockum I
Article: JOURNAL OF INTERNAL MEDICINE. 2011;270(3):229-236
Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
Malarstig A; Silveira A; Wagsater D; Ohrvik J; Backlund A; Samnegard A; Khademi M; Hellenius M-L; Leander K; Olsson T; Uhlen M; de Faire U; Eriksson P; Hamsten A
Article: NEUROLOGY. 2011;77(6):580-588
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Proebstel AK; Dornmair K; Bittner R; Sperl P; Jenne D; Magalhaes S; Villalobos A; Breithaupt C; Weissert R; Jacob U; Krumbholz M; Kuempfel T; Blaschek A; Stark W; Gaertner J; Pohl D; Rostasy K; Weber F; Forne I; Khademi M; Olsson T; Brilot F; Tantsis E; Dale RC; Wekerle H; Hohlfeld R; Banwell B; Bar-Or A; Meinl E; Derfuss T
Article: PLOS ONE. 2011;6(5):e19138
The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis
Iacobaeus E; Amoudruz P; Strom M; Khademi M; Brundin L; Hillert J; Kockum I; Malmstrom V; Olsson T; Tham E; Piehl F
Article: MULTIPLE SCLEROSIS JOURNAL. 2011;17(3):335-343
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
Article: JOURNAL OF LIPID RESEARCH. 2011;52(1):170-174
High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?
Bjorkhem I; Lovgren-Sandblom A; Piehl F; Khademi M; Pettersson H; Leoni V; Olsson T; Diczfalusy U
Article: MULTIPLE SCLEROSIS JOURNAL. 2011;17(1):32-42
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Bornsen L; Khademi M; Olsson T; Sorensen PS; Sellebjerg F
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(5):363-372
Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus
Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallstrom E; Svenungsson E; Andersson M
Article: JOURNAL OF IMMUNOLOGY. 2010;185(6):3574-3582
Maternal MHC Regulates Generation of Pathogenic Antibodies and Fetal MHC-Encoded Genes Determine Susceptibility in Congenital Heart Block
Strandberg LS; Ambrosi A; Jagodic M; Dzikaite V; Janson P; Khademi M; Salomonsson S; Ottosson L; Klauninger R; Aden U; Sonesson S-E; Sunnerhagen M; de Graaf KL; Kuchroo VK; Achour A; Winqvist O; Olsson T; Wahren-Herlenius M
Article: MULTIPLE SCLEROSIS JOURNAL. 2010;16(9):1056-1065
Interleukin 18 Receptor 1 expression distinguishes patients with multiple sclerosis
Gillett A; Hedreul MT; Khademi M; Espinosa A; Beyeen AD; Jagodic M; Kockum I; Harris RA; Olsson T
Article: GENES AND IMMUNITY. 2010;11(4):279-293
RGMA and IL21R show association with experimental inflammation and multiple sclerosis
Nohra R; Beyeen AD; Guo JP; Khademi M; Sundqvist E; Hedreul M; Sellebjerg F; Smestad C; Oturai AB; Harbo HF; Wallstrom E; Hillert J; Alfredsson L; Kockum I; Jagodic M; Lorentzen J; Olsson T
Article: NEUROBIOLOGY OF DISEASE. 2010;37(3):613-621
Gene expression profiling in multiple sclerosis: A disease of the central nervous system, but with relapses triggered in the periphery?
Brynedal B; Khademi M; Wallstrom E; Hillert J; Olsson T; Duvefelt K
Article: SCIENCE TRANSLATIONAL MEDICINE. 2009;1(10):10ra21
A Role for VAV1 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Jagodic M; Colacios C; Nohra R; Dejean AS; Beyeen AD; Khademi M; Casemayou A; Lamouroux L; Duthoit C; Papapietro O; Sjoholm L; Bernard I; Lagrange D; Dahlman I; Lundmark F; Oturai AB; Soendergaard HB; Kemppinen A; Saarela J; Tienari PJ; Harbo HF; Spurkland A; Ramagopalan SV; Sadovnick DA; Ebers GC; Seddighzadeh M; Klareskog L; Alfredsson L; Padyukov L; Hillert J; Clanet M; Edan G; Fontaine B; Fournie GJ; Kockum I; Saoudi A; Olsson T
Article: NEUROLOGY. 2009;73(23):2003-2010
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
Sellebjerg F; Bornsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sorensen PS
Article: PLOS ONE. 2009;4(8):e6534
Increased Numbers of IL-7 Receptor Molecules on CD4+CD25-CD107a+T-Cells in Patients with Autoimmune Diseases Affecting the Central Nervous System
Vudattu NK; Kuhlmann-Berenzon S; Khademi M; Seyfert V; Olsson T; Maeurer MJ
Article: JOURNAL OF IMMUNOLOGY. 2009;182(11):6889-6895
TLR Activation Induces TNF-α Production from Adult Neural Stem/Progenitor Cells
Covacu R; Arvidsson L; Andersson A; Khademi M; Erlandsson-Harris H; Harris RA; Svensson MA; Olsson T; Brundin L
Article: RESPIRATORY RESEARCH. 2009;10(1):42
Altered expression of T cell Immunoglobulin-Mucin (TIM) molecules in bronchoalveolar lavage CD4⁺ T cells in sarcoidosis
Idali F; Wahlstrom J; Dahlberg B; Khademi M; Olsson T; Eklund A; Grunewald J
Article: NEUROLOGY. 2009;72(15):1322-1329
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJA; Schepens M; Bouwman F; Twaalfhoven HAM; Blom HJ; Jakobs C; Dijkstra CD
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2009;16(4):528-536
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
Khademi M; Bornsen L; Rafatnia F; Andersson M; Brundin L; Piehl F; Sellebjerg F; Olsson T
Article: JOURNAL OF PROTEOMICS. 2009;71(6):670-681
Identification of novel candidate protein biomarkers for the post-polio syndrome - implications for diagnosis, neurodegeneration and neuroinflammation
Gonzalez H; Ottervald J; Nilsson KC; Sjogren N; Miliotis T; Von Bahr H; Khademi M; Eriksson B; Kjellstrom S; Vegvari A; Harris R; Marko-Varga G; Borg K; Nilsson J; Laurell T; Olsson T; Franzen B
Article: MULTIPLE SCLEROSIS JOURNAL. 2009;15(1):28-35
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA
Iacobaeus E; Ryschkewitsch C; Gravell M; Khademi M; Wallstrom E; Olsson T; Brundin L; Major EO
Article: MULTIPLE SCLEROSIS JOURNAL. 2008;14(5):622-630
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis:: interferon-β treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression
Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2008;15(3):309-312
Induction of systemic TNFα in Natalizumab-treated multiple sclerosis
Khademi M; Stol D; Olsson T; Wallstrom E
Article: NATURE GENETICS. 2007;39(9):1108-1113
Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis
Lundmark F; Duvefelt K; Iacobaeus E; Kockum I; Wallstroem E; Khademi M; Oturai A; Ryder LP; Saarela J; Harbo HF; Celius EG; Salter H; Olsson T; Hillert J
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2006;64(6):609-622
Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis
Tham E; Gielen AW; Khademi M; Martin C; Piehl F
Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(9):1237-1240
No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab
Andersson M; Svenungsson E; Khademi M; Lampa J; Brundin L; Wallstrom E
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2006;64(2):155-163
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis
Krakauer M; Sorensen PS; Khademi M; Olsson T; Sellebjerg F
Article: JOURNAL OF NEUROINFLAMMATION. 2005;2:26
Cytokine responses during chronic denervation
Ruohonen S; Khademi M; Jagodic M; Taskinen H-S; Olsson T; Roytta M
Article: JOURNAL OF NEUROIMMUNOLOGY. 2005;165(1-2):192-200
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
Furlan R; Rovaris M; Boneschi FM; Khademi M; Bergami A; Gironi M; Deleidi M; Agosta F; Franciotta D; Scarpini E; Uccelli A; Zaffaroni M; Kurne A; Comi G; Olsson T; Filippi M; Martino G
Article: JOURNAL OF NEUROIMMUNOLOGY. 2005;164(1-2):93-104
Expression of T cell immunoglobulin- and mucin-domain-containing molecules-1 and-3 (TIM-1 and -3) in the rat nervous and immune systems
Gielen AW; Lobell A; Lidman O; Khademi N; Olsson T; Piehl F
Article: NATURE GENETICS. 2005;37(5):486-494
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction
Swanberg M; Lidman O; Padyukov L; Eriksson P; Åkesson E; Jagodic M; Lobell A; Khademi M; Borjesson O; Lindgren CM; Lundman P; Brookes AJ; Kere J; Luthman H; Alfredsson L; Hillert J; Klareskog L; Hamsten A; Piehl F; Olsson T
Article: JOURNAL OF NEUROTRAUMA. 2004;21(7):969-975
Distinct expression of TGF-β1 mRNA in the endo- and epineurium after nerve injury
Taskinen HS; Ruohonen S; Jagodic M; Khademi M; Olsson T; Röyttä M
Article: JOURNAL OF IMMUNOLOGY. 2004;172(11):7169-7176
T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis
Khademi M; Illés Z; Gielen AW; Marta M; Takazawa N; Baecher-Allan C; Brundin L; Hannerz J; Martin C; Harris RA; Hafler DA; Kuchroo VK; Olsson T; Piehl F; Wallström E
Article: JOURNAL OF NEUROIMMUNOLOGY. 2004;150(1-2):139-144
Prior poliomyelitis -: IvIg treatment reduces proinflammatory cytokine production
Gonzalez H; Khademi M; Andersson M; Piehl F; Wallström E; Borg K; Olsson T
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2003;57(5):493-497
Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients
Gielen A; Khademi M; Muhallab S; Olsson T; Piehl F
Article: JOURNAL OF REPRODUCTIVE IMMUNOLOGY. 2003;58(1):49-59
In-situ detection of both inflammatory and anti-inflammatory cytokines in resting peripheral blood mononuclear cells during pregnancy
Matthiesen L; Khademi M; Ekerfelt C; Berg G; Sharma S; Olsson T; Ernerudh J
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 2002;205(1):9-13
Prior poliomyelitis-evidence of cytokine production in the central nervous system
Gonzalez H; Khademi M; Andersson M; Wallström E; Borg K; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 2002;132(1-2):11-17
Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1β, TGF-β1, TNF-α, and IL-10
Ruohonen S; Jagodi M; Khademi M; Taskinen HS; Ojala P; Olsson T; Röyttä M
Article: ANNALS OF NEUROLOGY. 2002;51(4):467-474
Antibody-mediated suppression of Vβ5.2/5.3⁺ T cells in multiple sclerosis:: Results from an MRI-monitored phase II clinical trial
Killestein J; Olsson T; Wallström E; Svenningsson A; Khademi M; Blumhardt LD; Fagius J; Hillert J; Landtblom AM; Edenius C; Årfors L; Barkhof F; Polman CH
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2002;9(2):153-164
Depletion of Vβ5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis
Olsson T; Edenius C; Ferm M; Samuelson P; Torrång A; Wallström E; Khademi M; Andersson M; Årfors L
Article: JOURNAL OF NEUROIMMUNOLOGY. 2001;116(2):168-177
Curative effects of recombinant human interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis
Di Marco R; Khademi M; Wallstrom E; Iacobaeus E; Salvaggio A; Caracappa S; Papoian R; Nicoletti F; Olsson T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2001;60(4):372-379
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus
Svenungsson E; Andersson M; Brundin L; van Vollenhoven R; Khademi M; Tarkowski A; Greitz D; Dahlström M; Lundberg I; Klareskog L; Olsson T
Article: ANNALS OF THE RHEUMATIC DISEASES. 2000;59(6):439-447
Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment
Ulfgren AK; Gröndal L; Lindblad S; Khademi M; Johnell O; Klareskog L; Andersson U
Article: JOURNAL OF NEUROIMMUNOLOGY. 2000;103(2):202-210
Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis
Khademi M; Wallström E; Andersson M; Piehl F; Di Marco R; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 2000;102(1):17-25
Peripheral nerve injury induces endoneurial expression of IFN-γ, IL-10 and TNF-α mRNA
Taskinen HS; Olsson T; Bucht A; Khademi M; Svelander L; Röyttä M
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2000;7(1):71-76
Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+and the CD8+subsets
Wallström E; Khademi M; Andersson M; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 1999;101(1):87-97
Non-MHC gene regulation of nerve root injury induced spinal cord inflammation and neuron death
Piehl F; Lundberg C; Khademi M; Bucht A; Dahlman I; Lorentzen JC; Olsson T
Article: JOURNAL OF NEUROIMMUNOLOGY. 1999;101(1):76-86
Expression of MHC class I heavy chain and β2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons
Lindå H; Hammarberg H; Piehl F; Khademi M; Olsson T
Article: JOURNAL OF AUTOIMMUNITY. 1999;13(2):187-195
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-γ and TNF-α and enhancement of IL-10
Di Marco R; Khademi M; Wallstrom E; Muhallab S; Nicoletti F; Olsson T
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 1998;28(10):3329-3335
Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
Wallström E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
Journal article: JOURNAL OF NEUROIMMUNOLOGY. 1998;90(1):38
Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis
Wallstrom E; Khademi M; Andersson M; Weissert R; Linington C; Olsson T
Journal article: JOURNAL OF NEUROIMMUNOLOGY. 1998;90(1):30
Strain dependent differences in the inflammatory response to mechanical nerve injuries
Piehl F; Lundberg C; Khademi M; Olsson T
Article: EXPERIMENTAL NEUROLOGY. 1998;150(2):282-295
Expression of MHC class I and β₂-microglobulin in rat spinal motoneurons: Regulatory influences by IFN-gamma and axotomy
Lindå H; Hammarberg H; Cullheim S; Levinovitz A; Khademi M; Olsson T
Article: EUROPEAN JOURNAL OF NEUROLOGY. 1997;4(6):567-571
Cytokine profile in interferon-β treated multiple sclerosis patients: reduction of interleukin-10 mRNA expressing cells in peripheral blood
Andersson M; Khademi M; Wallstrom E; Olsson T
Journal article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 1997;150:s252
4-31-23 T cell epitopes of myelin oligodendrocyte glycoprotein in multiple sclerosis
Wallström E; Khademi M; Andersson M; Linington C; Olsson T
Article: JOURNAL OF THE NEUROLOGICAL SCIENCES. 1996;137(2):89-96
Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis
Wallstrom E; Diener P; Ljungdahl A; Khademi M; Nilsson CG; Olsson T
Visa fler

Alla övriga publikationer

Corrigendum: FRONTIERS IN IMMUNOLOGY. 2024;15:1494595
Erratum: Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy
Lingehed GP; Hellberg S; Huang J; Khademi M; Kockum I; Carlsson H; Tjernberg I; Svenvik M; Lind J; Blomberg M; Vrethem M; Mellergard J; Gustafsson M; Jenmalm MC; Olsson T; Ernerudh J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):8-9
Anoctamin-2 is Encephalitogenic and is a Target of EBNA1 Adaptive Immune Responses in Multiple Sclerosis
Thomas O; Rykaczewska U; Galesic M; Bronge M; van der Burgt R; Marti Z; Akpinar B; Rique AH; Adzemovic MZ; Hogelin KA; Nilsson O; Holmgren E; Gafvelin G; Khademi M; Al Nimer F; Piehl F; Graslund T; Martin R; Kockum I; Cacais AOG; Gronlund H; Olsson T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):488
IgG antibodies against Rubella E1 are associated with HLA-DRB1*15: 01 and increased risk of multiple sclerosis
Huang J; Lima I; Butt J; Brenner N; Khademi M; Stridh P; Hillert J; Alfredsson L; Waterboer T; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):335
B cells repopulating after rituximab display increased activation at the single-cell transcriptomic level, despite absence of clinical disease activity
Cucuzza CS; Sorini C; Needhamsen M; Reinsbach S; Bjorklund A; Khademi M; Ruffin N; Jagodic M; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):1180-1181
Combined granulocyte activation (GAM) and astrocyte damage (ADM) markers in CSF allow the expedited differentiation between myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD) and MS
Furlan R; Schadelin S; Finardi A; Watanabe M; Piehl F; Fink K; Evertsson B; Khademi M; Gastaldi M; Greco G; Mariotto S; Battistini JL; Di Sapio A; Benkert P; Maceski AM; Oechtering J; Probstel A-K; Pretzsch R; Anthony D; Kuhle J; Leppert D
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2024;30(3):233
Memory B cells drive follicular helper T cell differentiation in Multiple Sclerosis
Ruffin N; Oughton J; Cucuzza CS; Alexe PI; Khademi M; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:637-638
Comparative efficacy of rituximab and other first line or first escalation options on treatment persistence, relapse rates, disability and serum neurofilament levels in a single center relapsing-remitting multiple sclerosis cohort
Trogu F; Cucuzza CS; Armiento M; Benkert P; Maceski AM; Kuhle J; Khademi M; Alping P; Granberg T; Ouellette R; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:300-301
Differentiating multiple sclerosis through the proteomic profiling of metabolic and neurological processes
Huang J; Nyren LN; Axelsson M; Malmestrom C; Khademi M; Piehl F; Constantinescu C; Lycke J; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:294-295
Soluble biomarker profiling in cerebrospinal fluid and serum of persons with MS experiencing symptom worsening under antiCD20 treatment as stratified by presence or absence of paramagnetic rim lesions
Cucuzza CS; Sandberg E; Ouellette R; Wojcik J; Khademi M; Maceski AM; Olsson T; Granziera C; Leppert D; Kuhle J; Granberg T; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:241-242
The immune response to EBV viral infection in untreated persons with Multiple Sclerosis and after B cell depletion
Hogelin KA; Kakhki MP; Gao Y; Margerie L; Ruffin N; Khademi M; Jagodic M; Olsson T; Buggert M; Al Nimer F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:482-483
Alpha crystallin B: EBNA1 antibody cross-reactivity and T cell responses in multiple sclerosis
Thomas O; Bronge M; Tengvall K; Akpinar B; Nilsson O; Holmgren E; Hessa T; Gafvelin G; Khademi M; Alfredsson L; Martin R; Cacais AOG; Gronlund H; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:942-944
The MultipleMS prospective cohort study: Induced changes in monocytes, T cells, and B cells from multiple sclerosis immunomodulatory treatments are associated with long-term disability progression and relapses
Moylett S; Neumann J; Berge T; Ruffin N; d'alfonso S; Leone M; Cavalla P; Gallo A; Gajofatto A; Vecchio D; Esposito F; Ferre L; Santoro S; Giordano A; Filippi M; Giovanni MBF; Kockum I; Piehl F; Moridi T; Granberg T; Jagodic M; Khademi M; Al Nimer F; Gustavsen S; Olsson AG; Soendergaard HB; Berg-Hansen P; Hogestol E; Flinstad HH; Bos-Haugen SD; Villoslada P; Llufriu S; Saiz A; Hemmer B; Humblet-Baron S; Goris A; Dubois B
Preprint: RESEARCH SQUARE. 2023
Increased cerebrospinal fluid levels of neuroinflammatory biomarkers in athletes with persistent symptoms following sports-related concussion
Gard A; Vedung F; Piehl F; Khademi M; Wernersson MP; Rorsman I; Tegner Y; Pessah-Rasmussen H; Ruscher K; Marklund N
Preprint: RESEARCH SQUARE. 2023
Proteomics profiling reveals biomarkers for predicting diagnosis, disease activity and long-term disability outcome in multiple sclerosis
Åkesson J; Hojjati S; Hellberg S; Raffetseder J; Khademi M; Rynkowski R; Kockum I; Altafini C; Lubovac-Pilav Z; Mellergård J; Jenmalm M; Piehl F; Olsson T; Ernerudh J; Gustafsson M
Preprint: MEDRXIV. 2022
B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis
Ulutekin C; Galli E; Khademi M; Callegari I; Piehl F; Sanderson N; Filippi M; Furlan R; Olsson T; Derfuss T; Ingelfinger F; Becher B
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):223
Extensive evidence for aberrant B cell hypomethylation in relapsing-remitting multiple sclerosis
Ewing E; Al Nimer F; Fernandes SJ; Kular L; Stridh P; Noori P; Gomez-Cabrero D; Tegner J; Khademi M; Olsson T; Piehl F; Jagodic M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):233-234
Re-visiting αβ-crystallin: EBNA1 antibody crossreactivity and CRYAB-specific T cell responses in multiple sclerosis
Thomas O; Bronge M; Tengvall K; Gyllenberg A; Hellstrom C; Holmgren E; Graslund T; Khademi M; Martin R; Nilsson P; Gafvelin G; Gronlund H; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):103-104
Humoral and cellular immune responses after SARSCoV-2-Vaccination in a Swedish cohort of persons with multiple sclerosis treated with disease modifying therapies
Rabenstein M; Thomas OG; Carlin G; Hellstrom C; Nilsson P; Khademi M; Hogelin KA; Lycke J; Malmestrom C; Axelsson M; Brandt AF; Gafvelin G; Gronlund H; Kockum I; Piehl F; Olsson T; Hessa T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):590
Identifying multiple sclerosis biomarkers in blood using high-sensitivity technologies
Huang J; Khademi M; Piehl F; Olsson T; Kockum I
Preprint: MEDRXIV. 2022
Plasma protein profiling of multiple sclerosis using proximity extension assays
Huang J; Khademi M; Piehl F; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):344-345
T cell reactivity screening reveals four novel CNS autoantigens in multiple sclerosis
Bronge M; Asplund Hogelin K; Thomas OG; Ruhrmann S; Carvalho-Querioz C; Nilsson O; Kaiser A; Holmgren E; Linnerbauer M; Adzemovic MZ; Zeitelhofer M; Hellstrom C; Jelcic I; Liu H; Nilsson P; Hillert J; Brundin L; Fink K; Martin R; Tegel H; Graslund T; Al Nimer F; Guerreiro-Cacais AO; Khademi M; Gafvelin G; Olsson T; Gronlund H
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):348
Impact of B-cell depleting treatments on development of humoral and cellular immunological memory against SARS-CoV-2
Hogelin KA; Ruffin N; Jiang X; Pin E; Manberg A; Hober S; Gafvelin G; Gronlund H; Frisell T; Nilsson P; Khademi M; Olsson T; Piehl F; Al Nimer F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):351
No evidence of rebound MS disease activity with presence of CD20⁺ T cells at B-cell reconstitution after treatment with rituximab
Ruffin N; Asplund-Hogelin K; Khademi M; Al Nimer F; Piehl F
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Development of Humoral and Cellular Immunological Memory Against SARS-CoV-2 Despite B-Cell Depleting Treatment in Multiple Sclerosis
Asplund Högelin K; Ruffin N; Pin E; Månberg A; Hober S; Gafvelin G; Grönlund H; Nilsson P; Khademi M; Olsson T; Piehl F; Al Nimer F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):368
Investigating a role of b cells and their depletion in relapsing-remitting multiple sclerosis using dna methylation patterns
Ewing E; Al Nimer F; Kular L; Carlstrom K; Stridh P; Olsson T; Khademi M; Gomez-Cabrero D; Piehl F; Jagodic M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):183-184
Profiling of small non-coding rnas across cellular and biofluid compartments in patients with multiple sclerosis
Zheleznyakova G; Piket E; Needhamsen M; Hagemann-Jensen M; Ekman D; Khademi M; Al Nimer F; Scicluna P; Faridani O; Olsson T; Piehl F; Jagodic M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):572
Dna methylation of cerebrospinal fluid cells in multiple sclerosis
Zheleznyakova G; Han Y; Ivanova E; Khademi M; Piehl F; Olsson T; Kelsey G; Needhamsen M; Jagodic M
Preprint: BIORXIV. 2020
Profiling of small non-coding RNAs across cellular and biofluid compartments: implications for multiple sclerosis immunopathology
Zheleznyakova GY; Piket E; Needhamsen M; Hagemann-Jensen M; Ekman D; Khademi M; Nimer FA; Scicluna P; Faridani O; Olsson T; Piehl F; Jagodic M
Review: JAMA NEUROLOGY. 2019;76(9):1035-1048
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis
Bridel C; van Wieringen WN; Zetterberg H; Tijms BM; Teunissen CE; Alvarez-Cermeno JC; Andreasson U; Axelsson M; Backstrom DC; Bartos A; Bjerke M; Blennow K; Boxer A; Brundin L; Burman J; Christensen T; Fialova L; Forsgren L; Frederiksen JL; Gisslen M; Gray E; Gunnarsson M; Hall S; Hansson O; Herbert MK; Jakobsson J; Jessen-Krut J; Janelidze S; Johannsson G; Jonsson M; Kappos L; Khademi M; Khalil M; Kuhle J; Landen M; Leinonen V; Logroscino G; Lu C-H; Lycke J; Magdalinou NK; Malaspina A; Mattsson N; Meeter LH; Mehta SR; Modvig S; Olsson T; Paterson RW; Perez-Santiago J; Piehl F; Pijnenburg YAL; Pyykko OT; Ragnarsson O; Rojas JC; Christensen JR; Sandberg L; Scherling CS; Schott JM; Sellebjerg FT; Simone IL; Skillback T; Stilund M; Sundstrom P; Svenningsson A; Tortelli R; Tortorella C; Trentini A; Troiano M; Turner MR; van Swieten JC; Vagberg M; Verbeek MM; Villar LM; Visser PJ; Wallin A; Weiss A; Wikkelso C; Wild EJ
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:81-82
Serological response against HHV-6A is associated with increased risk for multiple sclerosis
Engdahl E; Gustafsson R; Huang J; Bistrom M; Bomfim IL; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedstrom AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundstrom P; Olsson T; Kockum I; Fogdell-Hahn A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:221
Sensitive detection of rare myelin oligodendrocyte glycoprotein-specific T-cells in multiple sclerosis
Bronge M; Ruhrmann S; Carvalho-Queiroz C; Nilsson O; Kaiser A; Holmgren E; Macrini C; Winklmeier S; Meinl E; Brundin L; Khademi M; Olsson T; Gafvelin G; Groenlund H
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:212
Genomic comparison of immune cells in the periphery and the central nervous system in multiple sclerosis patients
Bedri SK; Evertsson B; Khademi M; Olsson T; Hillert J; Glaser A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:730-731
Association of CSF osteopontin levels with HLA and disease phenotypes in multiple sclerosis
Moridi T; Granberg T; Stridh P; Stawiarz L; Khademi M; Hillert J; Piehl F; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:436-437
Paired ATAC Seq and RNA Seq in blood derived CD4, CD8, CD14 and CD19 cells of MS patients and healthy controls
Fernandes SJ; Ericsson M; Khademi M; Olsson T; Gomez-Cabrero D; Kockum I; Tegner J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:726
Genome-wide small-noncoding RNA analysis in patients with multiple sclerosis
Zheleznyakova G; Piket E; Needhamsen M; Hagemann-Jensen M; Faridani O; Marabita F; Khademi M; Piehl F; Olsson T; Jagodic M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:498
Inflammation-related plasma and cerebrospinal fluid biomarkers for multiple sclerosis
Huang J; Khademi M; Fugger L; Piehl F; Olsson T; Kockum I
Preprint: BIORXIV. 2019
Increased serological response against human herpesvirus 6A is associated with risk for multiple sclerosis
Engdahl E; Gustafsson R; Huang J; Biström M; Bomfim IL; Stridh P; Khademi M; Brenner N; Butt J; Michel A; Jons D; Hortlund M; Alonso-Magdalena L; Hedström AK; Flamand L; Ihira M; Yoshikawa T; Andersen O; Hillert J; Alfredsson L; Waterboer T; Sundström P; Olsson T; Kockum I; Fogdell-Hahn A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:56
B - T cell interactions activate and maintain brain-homing T cells in multiple sclerosis.
Jelcic I; Al Nimer F; Wang J; Lentsch V; Planas R; Jelcic I; Madjovski A; Faigle W; Pinilla C; Santos R; Hammer C; Ortiz Y; Opitz L; Khademi M; Lutterotti A; Olsson T; Piehl F; Sospedra M; Martin R
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):296
Autophagy associated pathways regulate degradation of myelin debris and microglial phenotypes to determine clinical outcome of neuroinflammation
Berglund R; Guerreiro-Cacais AO; Ruhrmann S; Hedreul MT; Khademi M; Jagodic M; Olsson T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:643-644
ABO blood groups and secretion status is associated with JC polyomavirus antibody levels in plasma: a genome-wide association study
Huang J; Bomfim IL; Michel A; Link J; Khademi M; Brenner N; Butt J; Warnke C; Hillert J; Alfredsson L; Waterboer T; Olsson T; Kockum I
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2017;24:577
Neurofilament light in serum for monitoring multiple sclerosis: A new quantitative tool for measuring disease activity and therapeutic response
Novakova L; Zetterberg H; Axelsson M; Sundstrom P; Khademi M; Gunnarsson M; Malmestrom C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:859-860
Serological response against an immediately early protein 1 (IE1) protein sequence from HHV-6A, but not HHV-6B, is positively associated with multiple sclerosis
Engdahl E; Gustafsson R; Huang J; Bomfim IL; Khademi M; Michel A; Butt J; Brenner N; Hillert J; Alfredsson L; Waterboer T; Olsson T; Kockum I; Fogdell-Hahn A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:672
High sensitivity measurement of neurofilament-light levels in plasma demonstrates a significant reduction in multiple sclerosis patients starting fingolimod
Piehl F; Kockum I; Khademi M; Blennow K; Norgren N; Zetterberg H; Olsson T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:497
Genetic association of HLA alleles with JC polyomavirus and cross-reactivity with BK polyomavirus
Huang J; Bomfim IL; Michel A; Link J; Khademi M; Warnke C; Hillert J; Alfredsson L; Waterboer T; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:436-437
NOX genes - genetic markers for severe multiple sclerosis?
Gyllenberg A; Olsson LM; Acharjee B; Khademi M; Piehl F; Alfredsson L; Hillert J; Holmdahl R; Olsson T; Kockum I
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:633
Circulating miR-150 in cerebrospinal fluid is a novel biomarker for multiple sclerosis
Bergman P; Piket E; Khademi M; James T; Linden M; Kockum I; Brundin L; Piehl F; Olsson T; Jagodic M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:353-354
Relationships between CSF biomarkers of inflammation and degeneration in RRMS are also found in healthy controls
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmestrom C; Piehl F; Olsson T; Lycke J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:351-352
Cerebrospinal fluid kynurenines in multiple sclerosis: relation to disease course and neurocognitive symptoms
Stahl S; Aeinehband S; Brenner P; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:346
CSF biomarker levels of inflammation and degeneration in relapsing MS following switch to fingolimod from other disease modifying therapies
Axelsson M; Novakova L; Khademi M; Zetterberg H; Blennow K; Malmestrom C; Piehl F; Olsson T; Lycke J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2015;21:150
Endogenous soluble TACI is elevated in multiple sclerosis patients and shares functional properties with atacicept
Hoffmann FS; Kuhn P-H; Laurent SA; Hauck SM; Khademi M; Olsson T; Hohlfeld R; Lichtenthaler SF; Meinl E
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2014;275(1-2):136-137
A novel connection of autophagy related gene 7 to multiple sclerosis and experimental autoimmune encephalomyelitis
Berglund R; Hedreul MT; Parsa R; Bergman P; Jagodic M; Olsson T; Cacais AOG; Link J; Khademi M; Kockum I; Becher J; Cecconi F
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2014;275(1-2):65
Soluble BCMA is shed from B cells by gamma-secretase, functions as APRIL-specific decoy and reflects intrathecal Ig-production in multiple sclerosis
Laurent SA; Hoffmann F; Kuhn P-H; Hauck SM; Khademi M; Olsson T; Pfister H-W; Weber F; Hohlfeld R; Lichtenthaler SF; Meinl E
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2014;275(1-2):5-6
ADAM10 releases the immunoregulator soluble TACI - A novel biomarker for B-cell pathologies
Hoffmann F; Kuhn P-H; Laurent SA; Hauck SM; Berer K; Krumbholz M; Khademi M; Olsson T; Dreyling M; Pfister H-W; Alexander T; Hiepe F; Kuempfel T; Crawford HC; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2014;20:49-50
Anoctamin 2, a novel autoimmune target candidate in multiple sclerosis
Ayoglu B; Mitsios N; Khademi M; Alfredsson L; Uhlen M; Mulder J; Olsson T; Schwenk JM; Nilsson P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2014;20:250-251
Impact of genetic risk loci in multiple sclerosis on expression of proximal genes
James T; Linden M; Huss M; Brandi M; Khademi M; Tegner J; Gomez-Cabrero D; Kockum I; Olsson T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):33-34
Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS
Kuhle J; Dobson R; Bestwick JP; Topping J; Dalla Costa G; Khademi M; Sombekke M; Killestein J; Evdoshenko E; Lazareva N; Runia T; Zbornikova P; Horakova D; D'Alfonso S; Thouvenot E; Moll N; Hegen H; Rauch S; Khalil M; Fuchs S; Lindberg RLP; Derfuss T; Llufriu S; Franciotta D; Roesler R; Lauda F; Rajda C; Drulovic J; Menge T; Kieseier BC; Avsar T; Marignier R; Malmestrom C; Myhr KM; Wergeland S; Annibali V; Romano S; Carra A; Laroni A; Frederiksen JL; Larsson HB; Uccelli A; Martinez AD; Salvetti M; Torkildsen O; Lycke J; Confavreux C; Rejdak K; Bosca I; Brassat D; Scarpini E; Fenoglio C; Galimberti D; Siva A; Hartung HP; Dujmovic I; Vecsei L; Tumani H; Bergamaschi R; Colombo E; Villoslada P; Saiz A; Enzinger C; Kappos L; Deisenhammer F; Alvarez-Cermeno JC; Villar L; Pelletier J; Lehmann S; Castelnovo G; Barizzone N; Leone M; Havrdova E; Trojano M; Iaffaldano P; Direnzo V; Comabella M; Tintore M; Montalban X; Hintzen R; Lapin S; Teunissen C; Piehl F; Olsson T; Furlan R; Martinelli V; Comi G; Ramagopalan S; Giovannoni G
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):44-45
Validation of cerebrospinal fluid chitinase 3-like 1 as a prognostic biomarker of conversion to multiple sclerosis and disease severity in patients with clinically isolated syndromes
Canto E; Tintore M; Costa C; Arrambide G; Villar LM; Alvarez-Cermeno JC; Deisenhammer F; Hegen H; Khademi M; Olsson T; Piehl F; Bartos A; Simova D; Kotoucova J; Kuhle J; Kappos L; Garcia-Merino JA; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Tumani H; Lauda F; Roesler R; Rejdak K; Papuc E; de Andres C; Khalil M; Galimberti D; Scarpini E; Montalban X; Comabella M
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2013;19(11):22-23
Impact of genetic risk loci in multiple sclerosis on expression of proximal genes
James T; Linden M; Huss M; Brandi M; Khademi M; Tegner J; Gomez-Cabrero D; Kockum I; Olsson T
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2013;71:347
UNEXPECTED FINDING OF ANTI-CITRULLINATED PROTEIN ANTIBODIES (ACPA) IN CEREBROSPINAL FLUID OF RA PATIENTS WITH INTACT BLOOD BRAIN BARRIER - POTENTIAL FOR AUTOIMMUNE REACTIONS IN THE CNS
Le Maitre E; Lundberg K; Kosek E; Khademi M; Andersson M; Lampa J
Corrigendum: PLOS ONE. 2013;8(3):10.1371/annotation/b4e623
Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression.
Romme Christensen J; Börnsen L; Ratzer R; Piehl F; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):88-89
Variations in autophagy related gene Atg7 expression correlate to disease phenotypes in multiple sclerosis and experimental autoimmune encephalomyelitis
Berglund MTH; Berglund RB; Link J; Parsa R; Becher J; Bergman P; Khademi M; Cecconi F; Hillert J; Kockum I; Jagodic M; Olsson T
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):36
Secondary progressive multiple sclerosis is associated with an altered monocyte phenotype
Aeinehband S; Ruhrmann S; Parsa R; Khademi M; Olsson T; Jagodic M; Piehl F
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):163
Posttranslational modifications of myelin antigens and their role in MS pathology
Merky P; Khademi M; Haag S; Olsson T
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2012;253(1-2):100
Multivariate analysis of inflammatory and neuronal injury markers in cerebrospinal fluid of multiple sclerosis: Higher levels are associated with younger age
Khademi M; Dring A; Gilthorpe J; Wuolikainen A; Al Nimer F; Harris R; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2012;18:358
Multiple sclerosis risk genotypes correlate with elevated cerebrospinal fluid levels of the suggestive prognostic marker CXCL13
Linden M; Khademi M; Bomfim IL; Piehl F; Jagodic M; Kockum I; Olsson T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2012;18:366-367
Follicular T-helper cell activation in progressive multiple sclerosis
Christensen JR; Bornsen L; Ratzer R; Piehl F; Khademi M; Olsson T; Sorensen PS; Sellebjerg F
Conference publication: NEW BIOTECHNOLOGY. 2012;29:S20
Proteomic profiling of the autoimmunity repertoire in multiple sclerosis
Ayoglu B; Gundberg A; Khademi M; Olsson T; Uhl MN; Schwenk JM; Nilsson P
Conference publication: IMMUNOLOGY. 2012;137:663-664
Genetic risk variants in multiple sclerosis and gene expression in stimulated peripheral blood mononuclear cells
Linden M; Khademi M; Bedri SK; Jagodic M; Kockum I; Olsson T
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2012;19:30
Neurological side-effects of TNF-α blocking agents. A report of 39 cases
Roshanisefat H; Hopia L; Khademi M; Piehl F; Svenungsson E; Andersson M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):205-206
Genetic Risk Variants in Multiple Sclerosis and Gene Expression in Stimulated Peripheral Blood Mononuclear Cells
Linden M; Khademi M; Bedri SK; Jagodic M; Kockum I; Olsson T
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:A56
THE EXPRESSION OF SPLICE FORMS FOR THE RHEUMATOID ARTHRITIS RISK ASSOCIATED GENE PTPN22 IS SIGNIFICANTLY DIFFERENT FOR PATIENTS COMPARED TO CONTROLS
Ronninger M; Guo Y; Shchetynsky K; Hill A; Khademi M; Olsson T; Reddy PS; Seddighzadeh M; Clark JD; Lin L-L; O'Toole M; Padyukov L
Meeting abstract: ANNALS OF THE RHEUMATIC DISEASES. 2012;71:A36
UNEXPECTED FINDING OF ANTICITRULLINATED PROTEIN ANTIBODIES IN CEREBROSPINAL FLUID OF RA PATIENTS WITH INTACT BLOOD BRAIN BARRIER
Le Maitre E; Lundberg K; Kosek E; Khademi M; Andersson M; Lampa J
Letter: JOURNAL OF INTERNAL MEDICINE. 2011;270(5):496-499
Inflammatory and haemostatic markers in idiopathic intracranial hypertension
Hannerz J; Antovic JP; Blomback M; Edman G; Khademi M; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2011;17:S114
New evidence implicates IRF5 in the pathogenesis of multiple sclerosis
Bomfim IL; Wang C; Khademi M; Sandling J; Brynedal B; Lorentzen AR; Sondergaard HB; Oturai AB; Celius EG; Alfredsson L; Syvanen A-C; Kockum I; Olsson T; Hillert J
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2011;17:S119
Altered monocyte phenotype with decreased vascular endothelial growth factor-A in progressive multiple sclerosis
Iacobaeus E; Tham E; Khademi M; Olsson T; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2011;17:S358
Genetic influence on anti-JC-virus antibody seropositivity in MS patients and controls
Sundqvist E; Warnke C; Khademi M; Alfredsson L; Hillert J; Goelz S; Kockum I; Olsson T
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;72(3):269
MHC Genes Determine Fetal Susceptibility in a Rat Model of Congenital Heart Block
Dzikaite V; Strandberg LS; Ambrosi A; Jagodic M; Janson P; Khademi M; Salomonsson S; Ottosson L; Klauninger R; Aden U; Sonesson S-E; Sunnerhagen M; de Graaf KL; Kuchroo VK; Achour A; Winqvist O; Olsson T; Wahren-Herlenius M
Published conference paper: JOURNAL OF PROTEOMICS. 2010;73(6):1117-1132
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Ottervald J; Franzen B; Nilsson K; Andersson LI; Khademi M; Eriksson B; Kjellstrom S; Marko-Varga G; Vegvari A; Harris RA; Laurell T; Miliotis T; Matusevicius D; Salter H; Ferm M; Olsson T
Review: JOURNAL OF LEUKOCYTE BIOLOGY. 2008;84(5):1248-1255
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
Andersson A; Covacu R; Sunnemark D; Danilov AI; Dal Bianco A; Khademi M; Wallstrom E; Lobell A; Brundin L; Lassmann H; Harris RA
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2008;203(2):143
The effect of natalizumab treatment on cytokine profiles and clinical outcome measures in multiple sclerosis
Khademi M; Rafatnia F; Andersson M; Brundin L; Wallstroem E; Piehl F; Olsson T
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2008;14:S60
Global expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?
Brynedal B; Khademi M; Wallstroem E; Hillert J; Olsson TP; Duvefelt K
Corrigendum: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2007;65(3):310
Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis (vol 64, pg 609, 2006)
Tham E; Gielen AW; Khademi M; Martin C; Piehl F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2006;12:S15
N-acetylaspartate as a CSF marker for axonal damage in multiple sclerosis patients and controls
Teunissen C; Jacobeaus E; Khademi M; Brundin L; Verhoeven N; Jacobs C; Dijkstra C
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2006;12:S220
Abnormally low surface CTLA4 expression on CD25hi CD4+ T cells correlates with Foxp3 mRNA expression and is normalised by treatment with interferon-beta
Sellebjerg F; Krakauer M; Khademi M; Olsson T; Sorensen PS
Conference publication: EUROPEAN JOURNAL OF NEUROLOGY. 2006;13:28
Pro-inflammatory and immunoregulatory cytokines in interferon-treated multiple sclerosis
Krakauer M; Khademi M; Sorensen PS; Olsson T; Sellebjerg F
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2006;178:241
No signs of immunoactivation in the cerebrospinal fluid during infliximab treatment
Andersson M; Svenungsson E; Khademi M; Lampa J; Brundin L; Wallstrom E
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2006;178:210-211
No signs of immunoactivation in the cerebrospinal fluid during infliximab treatment
Andersson M; Svenungsson E; Khademi M; Lampa J; Brundin L; Wallstrom E
Conference publication: ARTHRITIS & RHEUMATOLOGY. 2006;54(9):S407
TNF-blocking therapy suppresses prostaglandin levels in cerebrospinal fluid of RA patients-correlations with functional disability.
Lampa J; Saha S; Svenungsson E; Khademi M; Wallström E; Gullström E; Andersson M; Jakobsson P-J
Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S119-S120
Increased expression of interleukin-10, tumor necrosis factor and interleukin-23 in Multiple Sclerosis patients treated with interferon-β.
Krakauer M; Khademi M; Sorensen P; Olsson T; Sellebjerg F
Meeting abstract: CLINICAL IMMUNOLOGY. 2006;119:S116-S117
Interleukin-7 receptor (IL-7R) mediated signaling effects in immune cells:novel readout for 'immune competence'
Vudattu N; Magalhaes I; Ahmed R; Schmidt M; Khademi M; Olsson T; Maeurer M
Conference publication: ANNALS OF THE RHEUMATIC DISEASES. 2005;64:78
The MHC2 transactivator gene polymorphism show association with differential MHC molecule expression and susceptibility to rheumatoid arthritis
Padyukov L; Eriksson R; Swanberg M; Khademi M; Börjesson O; Brookes A; Piehl F; Olsson T; Alfredsson L; Klareskog L
Doctoral thesis: 2005
Characterization and modulation of immunoregulatory molecules in neuroinflammation
Khademi M
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2004;154(1-2):104
TIM-3 and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis
Khademi M; Illés Z; Gielen AW; Marta M; Takazawa N; Baecher-Allan C; Brundin L; Hannerz J; Martin C; Harris RA; Hafler DA; Kuchroo V; Olsson T; Piehl F; Wallström E
Conference publication: JOURNAL OF NEUROIMMUNOLOGY. 2004;154(1-2):101
Immunological patterns identifying disease course and disease evolution in multiple sclerosis patients
Furlan R; Rovaris M; Boneschi FM; Khademi M; Bergami A; Gironi M; Deleidi M; Agosta F; Franciotta D; Scarpini E; Uccelli A; Zaffaroni M; Kurne A; Comi G; Olsson T; Filippi M; Martino G
Conference publication: BIOLOGY OF NITRIC OXIDE, PT 7. 2000;16:90
Nitric oxide formation in neuropsychiatric lupus erythematosus
Andersson M; Brundin L; Svenungsson E; Khademi M; Olsson T; Klareskog L; Lundberg I; Wiklund P
Visa fler

Anställningar

Senior Lab Manager, Klinisk neurovetenskap, Karolinska Institutet, 2022-

Examina och utbildning

MEDICINE DOKTORSEXAMEN, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2005

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI